Jumper's Knee Treatment & Management

  • Author: Garrett Scott Hyman, MD, MPH; Chief Editor: Craig C Young, MD   more...
 
Updated: Jul 1, 2011
 

Acute Phase

Rehabilitation Program

Physical Therapy

Most patients with jumper's knee (patellar tendinopathy, patellar tendinosis, patellar tendinitis) respond to a conservative management program, such as the one suggested below.

  • Activity modification: Decrease activities that increase patellofemoral pressure (eg, jumping, squatting). Possibly initiate gentle eccentric loading activities.[13, 22, 23]
  • Cryotherapy: Apply ice for 20-30 minutes, 4-6 times per day, especially after activity.
  • Joint motion and kinematics assessment: Evaluate hip, knee, and ankle joint ranges of motion.
  • Stretching: Stretch (1) flexors of the hip and knee (hamstrings, gastrocnemius, iliopsoas, rectus femoris, adductors), (2) extensors of the hip and knee (quadriceps, gluteals), (3) the iliotibial band, and (4) the patellar retinaculum.
  • Strengthening: Strengthen muscles using closed kinetic chain and eccentric exercise (ie, single-leg squat descents). Jonsson and Alfredson found eccentric quadriceps strengthening on a decline board superior to concentric strengthening in terms of pain, treatment satisfaction, and return to play.[13] Kongsgaard et al demonstrated that eccentric squats on a decline board of 25º increases patellar tendon loading versus standard eccentric squats on a level surface.[22]
  • Sport-specific proprioceptive training and plyometrics

Ultrasonography or phonophoresis may decrease pain symptoms. A patellofemoral brace with a patellar cutout and lateral stabilizer or McConnell taping may improve patellar tracking and provide stability through augmentation of proprioception. Provide arch supports or orthotics to correct foot malalignments.

Stage I

The treatment of jumper's knee is often specific to the degree of involvement. Stage I, which is characterized by pain only after activity and no undue functional impairment, is often treated with cryotherapy. The patient should use ice packs or ice massage after terminating the activity that exacerbates the pain and later again that evening. If aching persists, a course of regularly prescribed anti-inflammatory medications should be administered for 10-14 days.

Often, cryotherapy and anti-inflammatories suffice in the first stage, although some cases relapse once the course of anti-inflammatories is completed. Long-term use of anti-inflammatories should be avoided in the young athlete. Local corticosteroid injections are not advised in stage I treatment. In addition, most competitive athletes do not agree to rest and immobilization, given that the condition does not affect their performance at this point. For this reason, use of a counterforce strap has been suggested to relieve some of the tension on the affected area and thereby ameliorate the symptoms.

A comprehensive physical therapy program should include aggressive quadriceps and hip flexor stretching along with progressive strengthening. Begin with closed kinetic strengthening exercises, such as lunges, leg presses, and squats. Focus is given to the eccentric phase with each activity. Strict attention to proper technique is important to reduce stress on the patellofemoral joint and patellar tendon and to allow for progressive strengthening.

The strengthening program should progress to proprioceptive and plyometric exercises. Plyometrics include activities, such as jump roping, within the patient's pain tolerance. A good warm-up activity before stretching and strengthening is important to increase blood flow and tissue compliance. An exercise bicycle can be used to perform aerobic warm-up exercises. If significant anterior knee pain occurs, the seat should be adjusted slightly higher to eliminate excessive and repetitive knee flexion loading.

Stage II

In stage II, the patient has pain both during and after activity but is still able to participate in the sport satisfactorily. The pain may interfere with sleep. At this point, activities that cause increased loading of the patellar tendon (eg, running, jumping) should be avoided.

A comprehensive physical therapy program, as discussed above in Stage I, should be implemented. For pain relief, the knee should be protected by avoiding high loads to the patellar tendon, and cryotherapy should continue. The athlete should be instructed in alternative conditioning.

Once the pain improves, therapy should focus on knee, ankle, and hip joint ranges of motion; flexibility; and strengthening. Eccentric strengthening (perhaps on a decline board) should be emphasized because eccentric contractions allow for a greater generation of force and simulate landing in many sports. Advanced therapy should include plyometrics and sport-specific training, as tolerated.

If the pain becomes increasingly intense and if the athlete becomes more concerned about his or her performance, a local corticosteroid injection may be considered. The physician should explain that the steroid could cause further tendon degeneration, and perhaps even rupture, if the athlete begins loading the tendon too quickly once the symptoms improve.

Stage III

In stage III, the patient's pain is sustained, and performance and sport participation are adversely affected. Although discomfort increases, therapeutic measures similar to those described above should be continued, along with abstinence from the inciting activity. Relative rest for an extended period (eg, 3-6 wk) may be necessary in stage III. The athlete should avoid only those activities that incite the pain to prevent deconditioning, and he or she should be encouraged to continue an aggressive alternative cardiovascular and strength-training program.

If the pain is refractory to these measures, the options are limited. One can either abandon participation in jumping sports and/or consider surgery. In a randomized controlled trial, Bahr et al demonstrated no difference in outcome between surgical and nonsurgical treatment for patients with grade III tendinopathy.[24] The authors advocated 12 weeks of eccentric quadriceps strengthening before considering tenotomy. Only approximately half of athletes in both the surgical and nonsurgical treatment groups were well enough to return to sport within 1 year.[24]

Stage IV

Stage IV involves tendon rupture that requires surgical repair.

Medical Issues/Complications

Knee immobilization is contraindicated because it results in stiffness and may lead to muscle or joint contracture, further prolonging an athlete's return to play.

Surgical Intervention

Three principal surgical procedures include drilling of the involved pole, tendon excision, and resection of the involved pole.

Drilling of the involved pole

The goal of drilling is to increase the vascular supply to the affected area. This should allow for healing of the affected tendon and improve pain and tenderness. However, this procedure has yielded disappointing results.

Tendon excision

The second procedure involves longitudinal excision of the involved tendon, with subsequent restructuring of the residual tendon. Excision need not be limited to the tendon, as the inferior pole of the patella may be removed as well. The advantage of this procedure is that it does not disrupt the continuity of the quadriceps mechanism and allows for a relatively rapid return to play. On the other hand, visualization of the area is rather poor, and the clinician may overlook degradation of the patellar or peripatellar area or at the intercondylar portion of the femur, or they may even overlook degenerative changes in the tendon itself. Results have been mixed; some patients improve whereas others have been unable to return to their previous level of performance despite prolonged rest.

Resection of the involved pole

The third procedure calls for resection of the involved pole of the patella after inspection of the undersurface of the patella, the corresponding patellar face of the femur, and the involved tendon. Reattachment of the involved tendon and reinforcement of the medial patellar retinaculum are also parts of this procedure.

As reported by Blazina et al, the principal benefit is that this resection allows complete assessment of the extensor mechanism and provides the most suitable bed for favorable reattachment of the involved tendon into a raw, bony surface.[1] In addition, a tendon with degradation in multiple locations is best treated with such a procedure, as it enhances visualization of the affected area. Although this is the most involved procedure, it is effective in select patients. Complete overhaul of the entire extensor mechanism, however, is not required in many cases.

Open tenotomy was compared with an eccentric strengthening regimen in a randomized, controlled trial.[24] The authors found both surgery and the eccentric strengthening provided equivalent benefit in terms of pain reduction and functional improvement and return to sport at 1 year.

Consultations

Consultation with a physical medicine and rehabilitation specialist or an orthopedic specialist is recommended.

Other Treatment

  • Ultrasonographic-guided sclerosing injections into the neovascularized patellar tendon have shown promise in reducing pain and improving function in elite Norwegian basketball, volleyball, and handball players.[21]
  • Peritendinous corticosteroid/anesthetic injection
    • Consider this injection for patients with tendinitis in whom conservative therapy has failed.
    • The usual dose is triamcinolone 40 mg/1 mL (Kenalog, Bristol-Myers Squibb Co, Princeton, NJ; Aristospan, Lek Pharmaceuticals Inc, Princeton, NJ). Inject 0.5-1 mL, with or without 0.5-1 mL of a local anesthetic agent.
    • Use aseptic technique; prepare the area with alcohol or povidone-iodine solution (Betadine, Alcon Laboratories, Inc. Fort Worth, Tex).
    • Direct the injection into the most symptomatic peritendinous area (usually at or near the infrapatellar pole).
    • Fredberg and colleagues demonstrated efficacy of ultrasound-guided peritendinous steroid injections.[25]
    • Never inject directly into the patellar tendon because of the potential for patellar tendon rupture after the injection of corticosteroid.
    • Avoid repetitive corticosteroid injections in any site, as well as injection directly into a tendon, because of the risk of tendon rupture.
    • Following the injection, the patient should ice the injection site 3 times per day, 20 minutes at a time, for 48 hours after the injection.
    • The patient should avoid any running or jumping activities for 10-14 days after the injection.
    • In a systematic review by Coombes et al, the effects of corticosteroid injections were noted to provide only short-term benefit in studies pertaining to patella tendinopathy.[26]
  • James and colleagues evaluated ultrasound-guided dry needling and autologous blood injections, with promising results, in persons symptomatic longer than 12 months.[27] Interestingly, neovascularity did not reduce, and even increased, in some tendons.
  • Extracorporeal shock wave therapy (ESWT) provides comparable functional outcomes compared with surgery, according to Peers and colleagues.[28] ESWT was found to have no benefit over placebo in a randomized trial involving actively competing jumping athletes with symptoms for 3-12 months.[29]
Next

Recovery Phase

Rehabilitation Program

Physical Therapy

An in-depth, stage-specific description of a conservative therapy program is described above (see Acute Phase). In brief, in the recovery phase, the athlete and therapist should work to restore pain-free joint range of motion and muscle flexibility, symmetric strength in the lower extremities, and joint proprioception. Sport-specific training, including high-level plyometric exercises, should then be initiated.

Surgical Intervention

Surgical intervention is indicated for stage IV, as well as refractory stage III tendinopathy (see Acute Phase above).

Previous
Next

Maintenance Phase

Rehabilitation Program

Physical Therapy

An in-depth, stage-specific description of a conservative therapy program is described above (see Acute Phase). Briefly, once in the maintenance phase, the athlete should complete a sport-specific training program before returning to competition. The physician and physical therapist can assist the athlete in determining when to return to competition based on the patient's symptoms, current physical examination findings, and functional test results. Once the athlete returns to play, he or she must work to maintain gains in flexibility and strength.

Surgical Intervention

Surgical intervention is indicated for stage IV disease (see Acute Phase above).

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Garrett Scott Hyman, MD, MPH  Consulting Physician, Northwest Spine and Sports Physicians, PC; Clinical Assistant Professor, Department of Rehabilitation Medicine, University of Washington

Garrett Scott Hyman, MD, MPH is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American College of Sports Medicine, American Medical Association, and North American Spine Society

Disclosure: Nothing to disclose.

Coauthor(s)

Gerard A Malanga, MD  Director of Pain Management, Overlook Hospital; Director of PM&R Sports Medicine Fellowship, Atlantic Health; Clinical Professor, Department of Physical Medicine and Rehabilitation, UMDNJ-New Jersey Medical School; Clinical Chief, Rehabilitation Medicine and Electrodiagnosis, St Michael's Medical Center; Fellow, American College of Sports Medicine

Gerard A Malanga, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, American Institute of Ultrasound in Medicine, International Spine Intervention Society, and North American Spine Society

Disclosure: Cephalon Honoraria Speaking and teaching; Endo Honoraria Speaking and teaching; Genzyme Honoraria Speaking and teaching; Prostakan Honoraria Speaking and teaching; Pfizer Consulting fee Speaking and teaching

Irfan Alladin, MD  Staff Physician, Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry at New Jersey

Irfan Alladin, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation

Disclosure: Nothing to disclose.

Specialty Editor Board

Leslie Milne, MD  Assistant Clinical Instructor, Department of Emergency Medicine, Harvard University School of Medicine

Leslie Milne, MD is a member of the following medical societies: American College of Sports Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Russell D White, MD  Professor of Medicine, Director of Sports Medicine Fellowship Program, Medical Director, Sports Medicine Center, Head Team Physician, University of Missouri-Kansas City Intercollegiate Athletic Program, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood

Russell D White, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Family Physicians, American Association of Clinical Endocrinologists, American College of Sports Medicine, American Diabetes Association, and American Medical Society for Sports Medicine

Disclosure: Nothing to disclose.

Jon B Whitehurst, MD  Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital

Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America

Disclosure: Nothing to disclose.

Chief Editor

Craig C Young, MD  Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Director of Primary Care Sports Medicine Fellowship, Medical College of Wisconsin

Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, and Phi Beta Kappa

Disclosure: Nothing to disclose.

References
  1. Blazina ME, Kerlan RK, Jobe FW, Carter VS, Carlson GJ. Jumper's knee. Orthop Clin North Am. Jul 1973;4(3):665-78. [Medline].

  2. Almekinders LC, Vellema JH, Weinhold PS. Strain patterns in the patellar tendon and the implications for patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. Jan 2002;10(1):2-5. [Medline].

  3. Basso O, Amis AA, Race A, Johnson DP. Patellar tendon fiber strains: their differential responses to quadriceps tension. Clin Orthop Relat Res. Jul 2002;400:246-53. [Medline].

  4. Cook JL, Kiss ZS, Khan KM, Purdam CR, Webster KE. Anthropometry, physical performance, and ultrasound patellar tendon abnormality in elite junior basketball players: a cross-sectional study. Br J Sports Med. Apr 2004;38(2):206-9. [Medline]. [Full Text].

  5. Cook JL, Khan KM, Kiss ZS, Purdam CR, Griffiths L. Reproducibility and clinical utility of tendon palpation to detect patellar tendinopathy in young basketball players. Victorian Institute of Sport tendon study group. Br J Sports Med. Feb 2001;35(1):65-9. [Medline]. [Full Text].

  6. Cook JL, Khan KM, Kiss ZS, Purdam CR, Griffiths L. Prospective imaging study of asymptomatic patellar tendinopathy in elite junior basketball players. J Ultrasound Med. Jul 2000;19(7):473-9. [Medline].

  7. Busch MT. Sports medicine in children and adolescents. In: Morrissy RT, ed. Lovell and Winter's Pediatric Orthopaedics. Philadelphia, Pa: Lippincott-Raven; 1990:1091-1128.

  8. Ferretti A, Ippolito E, Mariani P, Puddu G. Jumper's knee. Am J Sports Med. Mar-Apr 1983;11(2):58-62. [Medline].

  9. Lian Ø, Refsnes PE, Engebretsen L, Bahr R. Performance characteristics of volleyball players with patellar tendinopathy. Am J Sports Med. May-Jun 2003;31(3):408-13. [Medline].

  10. Ferretti A. Epidemiology of jumper's knee. Sports Med. Jul-Aug 1986;3(4):289-95. [Medline].

  11. Kujala UM, Osterman K, Kvist M, Aalto T, Friberg O. Factors predisposing to patellar chondropathy and patellar apicitis in athletes. Int Orthop. 1986;10(3):195-200. [Medline].

  12. Witvrouw E, Bellemans J, Lysens R, Danneels L, Cambier D. Intrinsic risk factors for the development of patellar tendinitis in an athletic population. A two-year prospective study. Am J Sports Med. Mar-Apr 2001;29(2):190-5. [Medline].

  13. Jonsson P, Alfredson H. Superior results with eccentric compared to concentric quadriceps training in patients with jumper's knee: a prospective randomised study. Br J Sports Med. Nov 2005;39(11):847-50. [Medline].

  14. Scott A, Lian O, Bahr R, et al. Elevated mast cell numbers in human patellar tendinosis: correlation with symptom duration and vascular hyperplasia. Br J Sports Med. Mar 4 2008;epub ahead of print. [Medline]. [Full Text].

  15. Hamilton B, Purdam C. Patellar tendinosis as an adaptive process: a new hypothesis. Br J Sports Med. Dec 2004;38(6):758-61. [Medline]. [Full Text].

  16. [Best Evidence] Warden SJ, Kiss ZS, Malara FA, et al. Comparative accuracy of magnetic resonance imaging and ultrasonography in confirming clinically diagnosed patellar tendinopathy. Am J Sports Med. Mar 2007;35(3):427-36. [Medline].

  17. Alfredson H, Ohberg L. Neovascularisation in chronic painful patellar tendinosis--promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surg Sports Traumatol Arthrosc. Mar 2005;13(2):74-80. [Medline].

  18. Gisslén K, Alfredson H. Neovascularisation and pain in jumper's knee: a prospective clinical and sonographic study in elite junior volleyball players. Br J Sports Med. Jul 2005;39(7):423-8; discussion 423-8. [Medline]. [Full Text].

  19. Johnson DP, Wakeley CJ, Watt I. Magnetic resonance imaging of patellar tendonitis. J Bone Joint Surg Br. May 1996;78(3):452-7. [Medline]. [Full Text].

  20. Khan KM, Bonar F, Desmond PM, et al. Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Victorian Institute of Sport Tendon Study Group. Radiology. Sep 1996;200(3):821-7. [Medline]. [Full Text].

  21. [Best Evidence] Hoksrud A, Ohberg L, Alfredson H, Bahr R. Ultrasound-guided sclerosis of neovessels in painful chronic patellar tendinopathy: a randomized controlled trial. Am J Sports Med. Nov 2006;34(11):1738-46. [Medline].

  22. Kongsgaard M, Aagaard P, Roikjaer S, et al. Decline eccentric squats increases patellar tendon loading compared to standard eccentric squats. Clin Biomech (Bristol, Avon). Aug 2006;21(7):748-54. [Medline].

  23. Purdam CR, Jonsson P, Alfredson H, Lorentzon R, Cook JL, Khan KM. A pilot study of the eccentric decline squat in the management of painful chronic patellar tendinopathy. Br J Sports Med. Aug 2004;38(4):395-7. [Medline]. [Full Text].

  24. [Best Evidence] Bahr R, Fossan B, Løken S, Engebretsen L. Surgical treatment compared with eccentric training for patellar tendinopathy (jumper's knee). A randomized, controlled trial. J Bone Joint Surg Am. Aug 2006;88(8):1689-98. [Medline].

  25. Fredberg U, Bolvig L, Pfeiffer-Jensen M, et al. Ultrasonography as a tool for diagnosis, guidance of local steroid injection and, together with pressure algometry, monitoring of the treatment of athletes with chronic jumper's knee and Achilles tendinitis: a randomized, double-blind, placebo-controlled study. In: Scand J Rheumatol. 2004:33(2):94-101.

  26. Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. Nov 20 2010;376(9754):1751-67. [Medline].

  27. James SL, Ali K, Pocock C, et al. Ultrasound guided dry needling and autologous blood injection for patellar tendinosis. Br J Sports Med. Aug 2007;41(8):518-21; discussion 522. [Medline].

  28. Peers KH, Lysens RJ, Brys P, Bellemans J. Cross-sectional outcome analysis of athletes with chronic patellar tendinopathy treated surgically and by extracorporeal shock wave therapy. Clin J Sport Med. Mar 2003;13(2):79-83. [Medline].

  29. Zwerver J, Hartgens F, Verhagen E, van der Worp H, van den Akker-Scheek I, Diercks RL. No effect of extracorporeal shockwave therapy on patellar tendinopathy in jumping athletes during the competitive season: a randomized clinical trial. Am J Sports Med. Jun 2011;39(6):1191-9. [Medline].

  30. Al-Duri ZA, Aichroth PM. Surgical aspects of patellar tendonitis: technique and results. Am J Knee Surg. Winter 2001;14(1):43-50. [Medline].

  31. Cook JL, Khan KM, Harcourt PR, Grant M, Young DA, Bonar SF. A cross sectional study of 100 athletes with jumper's knee managed conservatively and surgically. The Victorian Institute of Sport Tendon Study Group. Br J Sports Med. Dec 1997;31(4):332-6. [Medline]. [Full Text].

  32. Lian Ø, Scott A, Engebretsen L, et al. Excessive apoptosis in patellar tendinopathy in athletes. Am J Sports Med. Apr 2007;35(4):605-11. [Medline].

  33. Matheson GO. Long-term prognosis for jumper's knee. Clin J Sport Med. May 2003;13(3):196. [Medline].

  34. Medlar RC, Lyne ED. Sinding-Larsen-Johansson disease. Its etiology and natural history. J Bone Joint Surg Am. Dec 1978;60(8):1113-6. [Medline]. [Full Text].

  35. Ogden JA, Southwick WO. Osgood-Schlatter's disease and tibial tuberosity development. Clin Orthop Relat Res. May 1976;116:180-9. [Medline].

  36. Roels J, Martens M, Mulier JC, Burssens A. Patellar tendinitis (jumper's knee). Am J Sports Med. Nov-Dec 1978;6(6):362-8. [Medline].

Previous
Next
 
The proximal patellar tendon is most commonly affected in jumper's knee.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.